Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer
出版年份 2020 全文链接
标题
Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-01-14
DOI
10.1038/s41598-019-57101-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PARP inhibitors for homologous recombination-deficient prostate cancer
- (2018) Eric S. Christenson et al. EXPERT OPINION ON EMERGING DRUGS
- microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer
- (2018) Ahmed Hussein Zedan et al. TUMOR BIOLOGY
- miRBase: from microRNA sequences to function
- (2018) Ana Kozomara et al. NUCLEIC ACIDS RESEARCH
- Circulating miRNAs in localized/locally advanced prostate cancer patients after radical prostatectomy and radiotherapy
- (2018) Ahmed H. Zedan et al. PROSTATE
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
- (2017) Philip Cornford et al. EUROPEAN UROLOGY
- The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies
- (2017) Chun-Jiao Song et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data
- (2017) Justin Guinney et al. LANCET ONCOLOGY
- Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
- (2017) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heterogeneity of miRNA expression in localized prostate cancer with clinicopathological correlations
- (2017) Ahmed Hussein Zedan et al. PLoS One
- Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer
- (2017) Bin Gui et al. PLoS One
- MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions
- (2016) Caterina Catalanotto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
- (2016) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer
- (2016) L A Selth et al. ONCOGENE
- Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
- (2015) Xiaoyi Huang et al. EUROPEAN UROLOGY
- Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
- (2014) H-M Lin et al. BRITISH JOURNAL OF CANCER
- Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
- (2014) B. Kneitz et al. CANCER RESEARCH
- Good guy or bad guy: the opposing roles of microRNA 125b in cancer
- (2014) Julia Banzhaf-Strathmann et al. Cell Communication and Signaling
- Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer
- (2014) Susan Halabi et al. JOURNAL OF CLINICAL ONCOLOGY
- Visceral Disease in Castration-resistant Prostate Cancer
- (2013) Carmel J. Pezaro et al. EUROPEAN UROLOGY
- Plasma miRNAs as Biomarkers to Identify Patients with Castration-Resistant Metastatic Prostate Cancer
- (2013) Akira Watahiki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Circulating microRNA Profiling Identifies a Subset of Metastatic Prostate Cancer Patients with Evidence of Cancer-Associated Hypoxia
- (2013) Heather H. Cheng et al. PLoS One
- Circulating microRNAs and Kallikreins before and after Radical Prostatectomy: Are They Really Prostate Cancer Markers?
- (2013) Maria Giulia Egidi et al. Biomed Research International
- Changes in circulating microRNA levels associated with prostate cancer
- (2012) R J Bryant et al. BRITISH JOURNAL OF CANCER
- Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
- (2012) Karim Fizazi et al. LANCET ONCOLOGY
- Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer
- (2012) Han Christine Ngoc Nguyen et al. PROSTATE
- miR-141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein
- (2012) Jing Xiao et al. PROSTATE
- Downregulation of Sec23A Protein by miRNA-375 in Prostate Carcinoma
- (2011) J. Szczyrba et al. MOLECULAR CANCER RESEARCH
- MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
- (2010) Zhang Chun-zhi et al. BMC CANCER
- The MicroRNA Spectrum in 12 Body Fluids
- (2010) J. A. Weber et al. CLINICAL CHEMISTRY
- Clinical significance of miR-221 and its inverse correlation with p27Kip1 in hepatocellular carcinoma
- (2010) Xinhui Fu et al. MOLECULAR BIOLOGY REPORTS
- Serum microRNAs as non-invasive biomarkers for cancer
- (2010) Jan C Brase et al. Molecular Cancer
- Drug resistance in metastatic castration-resistant prostate cancer
- (2010) Bostjan Seruga et al. Nature Reviews Clinical Oncology
- Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy
- (2010) Hai-Liang Zhang et al. PROSTATE
- Prostate-specific antigen: An evolving role in diagnosis, monitoring, and treatment evaluation in prostate cancer
- (2010) Heather Payne et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- MicroRNA-dependent regulation of cKit in cutaneous melanoma
- (2009) O. Igoucheva et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
- (2009) Michela Garofalo et al. CANCER CELL
- The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline and survival
- (2009) Andrew J. Armstrong et al. EUROPEAN JOURNAL OF CANCER
- Causes and consequences of microRNA dysregulation in cancer
- (2009) Carlo M. Croce NATURE REVIEWS GENETICS
- Castration-resistant prostate cancer: Targeting androgen metabolic pathways in recurrent disease
- (2009) Elahe A. Mostaghel et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study
- (2008) Dominik R. Berthold et al. JOURNAL OF CLINICAL ONCOLOGY
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More